A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma by Dylan B. Ness, Darcy B. Pooler, Steven Ades, Brian J. Highhouse, Bridget M. Labrie, Jie Zhou, Jiang Gui, Lionel D. Lewis, Marc S. Ernstoff

Get full text